Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apriwell
Berlin, Berlin, Germanyapriwell.de ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
Apriwell is a Berlin-based digital health company specializing in the treatment of chronic gastrointestinal conditions, with a primary focus on chronic constipation. The company offers a holistic, multi-modal therapy approach that combines a digital coaching application with personalized nutritional supplements and medical products. By integrating behavioral changes, dietary adjustments, and data-driven monitoring, Apriwell aims to provide long-term relief for patients who have not found success with traditional laxatives. Their platform is designed to address the root causes of digestive issues through a combination of telemedicine and self-management tools.
- Therapeutic areas
- Gastroenterology
- Modalities
- Digital healthNon-pharmacological therapyNutritional supplement
- Industry
- Digital Health Medical Devices
Beyond the preview
Go deeper on Apriwell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apriwell.